The complex reality of peptide analysis What initially drew us to work with GLP-1 RAs was the combination of their exciting therapeutic potential and the complex analytical challenges they present, demanding fit-for-purpose analytical procedures
Most commercial products undergo rigorous comedogenicity testing and irritation assessments
Highlights of prescribing information: Mounjaro
Figure 7 compares lipidomics data from 7 lipid species that showed differences in multiple brain regions in the current study to those same lipids in (e.g., HYP, CER, STR, THAL, CTX, and HIPP) of FAAH KO (Leishman et al., 2016), MAGL KO (Leishman et al., 2016), ABHD12 KO (Leishman et al., 2019), NAPE-PLD KO (Leishman et al., 2016), CB1 KO (Leishman et al., 2016), acute 3 mg/kg THC treatment (Leishman et al., 2018), and acute 3 mg/kg CBD treatment (Leishman et al., 2018)
Frequently Asked Questions How do GLP-1 receptor agonists improve metabolic function
(v) Ascendis collaboration with Novo Nordisk to maximize the potential of TransCon products
:max_bytes(150000):strip_icc():focal(988x217:990x219)/serena-williams-weight-loss-main-split-082125-db2860b201144cd2b1759765d8fc7595.jpg)
